JP Morgan Chase
UNCY icon

JP Morgan Chase’s Unicycive Therapeutics UNCY Stock Holding History

JP Morgan Chase’s Portfolio UNCY Stock Details UNCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-21,709
Closed -$104K – 7744
2025
Q2 		$104K Buy
21,709
+21,691
+120,506% +$134K ﹤0.01% 5590
2025
Q1 		$106 Sell
18
-2
-10% -$12 ﹤0.01% 6867
2024
Q4 		$158 Sell
20
-1
-5% -$6 ﹤0.01% 6945
2024
Q3 		$84 Buy
21
+14
+200% +$56 ﹤0.01% 7028
2024
Q2 		$35 Buy
7
+2
+40% +$20 ﹤0.01% 7091
2024
Q1 		$65 Buy
+5
New +$61 ﹤0.01% 6981

Other funds holding UNCY

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $46.5B AUM 20.93% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $141M AUM 783.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return